Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.

Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW.

Neoplasia. 2004 May-Jun;6(3):187-94.

2.
3.

Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.

Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW.

J Biol Chem. 2005 Mar 18;280(11):10047-54. Epub 2005 Jan 12.

4.

The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.

Love IM, Sekaric P, Shi D, Grossman SR, Androphy EJ.

Cell Cycle. 2012 Jul 1;11(13):2458-66. doi: 10.4161/cc.20864. Epub 2012 Jul 1.

5.

p73gamma transactivates the p21 promoter through preferential interaction with the p300/CBP-associated factor in human prostate cancer cells.

Momii Y, Izumi H, Shiota M, Onitsuka T, Abe T, Kobayashi H, Miyamoto N, Uchiumi T, Kohno K.

Oncol Rep. 2007 Aug;18(2):411-6.

PMID:
17611664
6.

Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.

Imbriano C, Gurtner A, Cocchiarella F, Di Agostino S, Basile V, Gostissa M, Dobbelstein M, Del Sal G, Piaggio G, Mantovani R.

Mol Cell Biol. 2005 May;25(9):3737-51.

7.

Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.

Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J, Franchini G.

J Biol Chem. 2003 Apr 4;278(14):12310-8. Epub 2002 Dec 24.

8.

MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation.

Jin Y, Zeng SX, Dai MS, Yang XJ, Lu H.

J Biol Chem. 2002 Aug 23;277(34):30838-43. Epub 2002 Jun 14.

9.
10.

HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB.

Wong K, Sharma A, Awasthi S, Matlock EF, Rogers L, Van Lint C, Skiest DJ, Burns DK, Harrod R.

J Biol Chem. 2005 Mar 11;280(10):9390-9. Epub 2004 Dec 15.

11.

Regulation of ERK1 gene expression by coactivator proteins.

Chu BY, Tran K, Ku TK, Crowe DL.

Biochem J. 2005 Dec 15;392(Pt 3):589-99.

12.

HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.

Di Stefano V, Soddu S, Sacchi A, D'Orazi G.

Oncogene. 2005 Aug 18;24(35):5431-42.

PMID:
15897882
13.

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL.

Mol Cell Biol. 1999 Feb;19(2):1202-9.

14.

Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2.

Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O, Lacroix M, Le Cam L, Coux O, Benkirane M.

Nat Cell Biol. 2007 Mar;9(3):331-8. Epub 2007 Feb 11.

PMID:
17293853
16.

Repression of new p53 targets revealed by ChIP on chip experiments.

Ceribelli M, Alcalay M, Viganò MA, Mantovani R.

Cell Cycle. 2006 May;5(10):1102-10. Epub 2006 May 15.

PMID:
16721047
17.

Functional interaction between coactivators CBP/p300, PCAF, and transcription factor FKLF2.

Song CZ, Keller K, Murata K, Asano H, Stamatoyannopoulos G.

J Biol Chem. 2002 Mar 1;277(9):7029-36. Epub 2001 Dec 17.

18.

Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation.

Shan B, Xu J, Zhuo Y, Morris CA, Morris GF.

J Biol Chem. 2003 Nov 7;278(45):44009-17. Epub 2003 Aug 28.

19.
20.

Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF.

Liu Y, Colosimo AL, Yang XJ, Liao D.

Mol Cell Biol. 2000 Aug;20(15):5540-53.

Supplemental Content

Support Center